Ivermectin not effective at reducing COVID-19 hospitalisations

Embargoed until: Publicly released: 2022-03-31 08:00

Australia; International; VIC

Photo by Roberto Sorin on Unsplash

A trial looking at several potential treatments for COVID-19 has found ivermectin does not reduce the risk of hospitalisation from the virus. International researchers looked at the outcomes of 679 patients treated with ivermectin compared with 679 people given a placebo treatment. They say there were no significant differences in the rate of patients needing hospital admission due to the virus.

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research Massachusetts Medical Society, Web page The URL will go live after the embargo ends

Journal/
conference: New England Journal of Medicine

Research:Paper

Organisation/s: Monash University

Funder: Funded by FastGrants and the Rainwater Charitable Foundation; TOGETHER ClinicalTrials. gov number, NCT04727424.

Media Contact/s

Contact details are only visible to registered journalists.